Search results for "Roca"

showing 10 items of 1893 documents

Prognostic Value of White Blood Cell Count in Acute Myocardial Infarction: Long-Term Mortality

2005

Although traditionally an elevated white blood cell count (WBC), an indicator of systemic inflammation, has been accepted as part of the healing response following acute myocardial infarction (AMI), it has frequently been shown to be a predictor of adverse cardiovascular events. The present study was designed to assess the association between WBC and long-term mortality in AMI patients either with ST-segment elevation (STEMI) or without ST-segment elevation (non-STEMI). Patients and method. The study included 1118 consecutive patients who were admitted with the diagnosis of AMI: 569 non-STEMI and 549 STEMI. The WBC was measured in the 24 hours following admission. Patients were divided into…

Malemedicine.medical_specialtyTime FactorsMyocardial InfarctionSystemic inflammationElectrocardiographyLeukocyte CountRisk FactorsInternal medicineWhite blood cellMyocardial RevascularizationmedicineHumansHospital Mortalitycardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronarySurvival analysisAgedProportional Hazards Modelsmedicine.diagnostic_testbusiness.industryProportional hazards modelHazard ratioGeneral MedicinePrognosismedicine.diseaseSurvival AnalysisSurgerysurgical procedures operativemedicine.anatomical_structureCardiologyRegression AnalysisFemaleLong term mortalitymedicine.symptombusinessElectrocardiographyFollow-Up StudiesRevista Española de Cardiología (English Edition)
researchProduct

Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction.

2007

Neutrophil to lymphocyte ratio (N/L) has been associated with poor outcomes in patients who underwent cardiac angiography. Nevertheless, its role for risk stratification in acute coronary syndromes, specifically in patients with ST-segment elevation myocardial infarction (STEMI), has not been elucidated. We sought to determine the association of N/L maximum value (N/L max) with mortality in the setting of STEMI and to compare its predictive ability with total white blood cell maximum count (WBC max). We analyzed 515 consecutive patients admitted with STEMI to a single university center. White blood cells (WBC) and differential count were measured at admission and daily for the first 96 hour…

Malemedicine.medical_specialtyTime FactorsNeutrophilsMyocardial InfarctionCoronary AngiographyElectrocardiographyLeukocyte CountWhite blood cellInternal medicineCause of DeathConfidence IntervalsST segmentMedicineHumansMyocardial infarctionLymphocytesNeutrophil to lymphocyte ratioAgedProportional Hazards ModelsRetrospective Studiesmedicine.diagnostic_testbusiness.industryProportional hazards modelST elevationMiddle Agedmedicine.diseasePrognosisSurvival Ratemedicine.anatomical_structureCardiologyFemaleMyocardial infarction diagnosisCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American journal of cardiology
researchProduct

Finding atrial fibrillation in stroke patients: Randomized evaluation of enhanced and prolonged Holter monitoring—Find-AFRANDOMISED —rationale and de…

2014

Background Detecting paroxysmal atrial fibrillation (AF) in patients with ischemic strokes presenting in sinus rhythm is challenging because episodes are often short, occur randomly, and are frequently asymptomatic. If AF is detected, recurrent thromboembolism can be prevented efficiently by oral anticoagulation. Numerous uncontrolled studies using various electrocardiogram (ECG) devices have established that prolonged ECG monitoring increases the yield of AF detection, but most established procedures are time-consuming and costly. The few randomized trials are mostly limited to cryptogenic strokes. The optimal method, duration, and patient selection remain unclear. Repeated prolonged conti…

Malemedicine.medical_specialtyTime FactorsPopulationAsymptomaticlaw.inventionRandomized controlled triallawGermanyInternal medicineMulticenter trialAtrial FibrillationPrevalencemedicineHumansSinus rhythmProspective Studiescardiovascular diseaseseducationStrokeAgededucation.field_of_studymedicine.diagnostic_testbusiness.industryIncidenceAtrial fibrillationmedicine.diseaseMagnetic Resonance Imaging3. Good healthSurgeryStrokeElectrocardiography AmbulatoryCardiologyFemalemedicine.symptomTomography X-Ray ComputedCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesAmerican Heart Journal
researchProduct

Relationship between HRV measurements and demographic and clinical variables in a population of patients with atrial fibrillation.

2015

Little is known about the role of HRV in atrial fibrillation (AF) patients. Aim of our study was to assess the relationship between HRV measurements and demographic and clinical variables in a population of 274 AF patients. We selected all consecutive patients with persistent/permanent AF among whom had performed a Holter ECG in our Department from April 2010 to April 2015. Time-domain analysis of HRV was evaluated. Demographic and clinical variables were collected for each patient. At multivariable logistic regression, a higher pNN50 was associated with ACE inhibitors/ARBs (p = 0.016) and a lower pNN50 with obesity (p = 0.037) and higher heart rate (HR) (p < 0.0005). A higher RMSSD w…

Malemedicine.medical_specialtyTime FactorsPopulationDigitalisComorbidity030204 cardiovascular system & hematologyAutonomic Nervous System03 medical and health sciences0302 clinical medicineHeart RateRisk FactorsInternal medicineHeart rateAtrial FibrillationmedicineHeart rate variabilityHumansSinus rhythm030212 general & internal medicineeducationStrokeHeart rate variabilityAgedRetrospective StudiesAged 80 and overeducation.field_of_studybiologybusiness.industryAtrial fibrillationHeartmedicine.diseasebiology.organism_classificationCardiac surgeryAntiarrhythmic drugCross-Sectional StudiesLogistic ModelsItalyMultivariate AnalysisCardiologyElectrocardiography AmbulatoryLinear ModelsPolypharmacyFemalebusinessCardiology and Cardiovascular MedicineAnti-Arrhythmia AgentsHolter ECGHeart and vessels
researchProduct

Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study

2018

Background: Impaired exercise capacity is the most disabling symptom in patients with heart failure with reduced ejection fraction (HFrEF). Despite sacubitril/valsartan showing reduced long-term morbidity and mortality over enalapril in HFrEF, its effects on short-term functional capacity remain uncertain. We sought to evaluate the effects of sacubilril/valsartan on a 30-day six-minute walk test in eligible patients with HFrEF. Methods and results: From November 1, 2016 to February 1, 2017, a total of 58 stable symptomatic patients with HFrEF were eligible for sacubitril/valsartan and underwent 6-MWT before and 30 days after initiation of sacubitril/valsartan therapy. A mixed-effects model …

Malemedicine.medical_specialtyTime FactorsTetrazolesPilot ProjectsWalk Test030204 cardiovascular system & hematologySacubitrilCohort Studies03 medical and health sciencesAngiotensin Receptor AntagonistsElectrocardiography0302 clinical medicineInternal medicineExercise capacityMedicineHumans6-minute walk test030212 general & internal medicineEnalaprilProspective StudiesSacubitril/valsartanAgedAged 80 and overEjection fractionExercise Tolerancebusiness.industryAminobutyratesBiphenyl CompoundsExercise capacityMiddle Agedmedicine.diseaseHeart failure with reduced ejection fractionDrug CombinationsTreatment OutcomeValsartanHeart failureCardiologyValsartanFemaleCardiology and Cardiovascular MedicinebusinessSacubitril Valsartanmedicine.drug
researchProduct

Influence of gender on delays and early mortality in ST-segment elevation myocardial infarction: Insight from the first French Metaregistry, 2005–201…

2018

International audience; Background - Women show greater mortality after acute myocardial infarction. We decided to investigate whether gender affects delays and impacts in-hospital mortality in a large population.Methods and results - We performed a patient-level analysis of 7 French MI registries from different regions from January 2005 to December 2012. All patients with acute STEMI were included within 12 h from symptom onset and a first medical contact with a mobile intensive care unit an emergency department of a hospital with percutaneous coronary intervention facility. Primary study outcomes were STEMI, patient and system, delays. Secondary outcome was in-hospital mortality. 16,733 p…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatment030204 cardiovascular system & hematologyCoronary AngiographyClinical researchSTEMIElectrocardiography03 medical and health sciencesSex Factors0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemRisk FactorsGender issuesmedicineHumansST segmentRegistries030212 general & internal medicineMyocardial infarctionSex DistributionSurvival rateAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbusiness.industryPercutaneous coronary interventionRetrospective cohort studyEmergency departmentMiddle Aged[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemPrognosismedicine.disease3. Good healthSurvival RateClinical researchEmergency medicineST Elevation Myocardial InfarctionFemale[SDV.IB]Life Sciences [q-bio]/BioengineeringCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesInternational Journal of Cardiology
researchProduct

Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.

2003

Abstract Aim: The aim of this study was to evaluate glycoprotein IIb/IIIa receptor inhibitor effectiveness in AMI patients with unsuccessful thrombolysis. Methods: Eighty-four patients hospitalised within 4 h of symptom onset were randomised (single blind) into two groups. Regardless of the group, placebo or GP IIb/IIIa inhibitors were administered to patients who did not present with reperfusion signs 30 min after starting thrombolysis and 30–60 min after the end of full thrombolysis in patients with pain recurrence and ST-segment elevation. Reperfusion was assessed by the creatine kinase peak occurring within 12 h, by the observation of rapid ST-segment reduction (50–70% within 1 h) in 12…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial ReperfusionPlatelet Glycoprotein GPIIb-IIIa ComplexPlaceboCoronary AngiographyAnginaElectrocardiographyImmunoglobulin Fab FragmentsInternal medicineFibrinolysisAbciximabmedicineHumansSingle-Blind MethodThrombolytic TherapyMyocardial infarctionTreatment FailureAngioplasty Balloon CoronaryAspirinbusiness.industryAntibodies MonoclonalThrombolysisMiddle Agedmedicine.diseaseTolerabilityResearch DesignAnesthesiaTissue Plasminogen ActivatorCardiologyFemaleSafetyCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugInternational journal of cardiology
researchProduct

Prognostic value of ST-segment resolution after rescue percutaneous coronary intervention. Data from the RICO survey

2008

Objectives: The goal of the present study was to test the impact of ST segment resolution (STR) after rescue percutaneous coronary intervention (PCI) on the short-term prognosis. Background: The prognostic value of STR after rescue PCI for acute ST elevation myocardial infarction (STEMI) remains undetermined. Methods: From the French regional database, we analyzed 168 consecutive patients with STEMI and failed lysis, defined by <50 percent STR, who underwent rescue PCI. Patients were classified into two groups according to the degree of STR from the maximal ST-elevation measured on the single worst ECG lead before lysis and after rescue PCI: the without STR group (<50% STR) vs. the with STR…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentMyocardial InfarctionRisk AssessmentElectrocardiographyCoronary CirculationInternal medicineOdds RatiomedicineHumansST segmentThrombolytic TherapyRadiology Nuclear Medicine and imagingProspective StudiesRegistriesTreatment Failurecardiovascular diseasesMyocardial infarctionAngioplasty Balloon CoronaryProspective cohort studyAgedIntra-Aortic Balloon Pumpingmedicine.diagnostic_testbusiness.industryPercutaneous coronary interventionGeneral MedicineThrombolysisMiddle AgedPrognosismedicine.diseaseeye diseasesSurgeryTreatment OutcomeCardiovascular DiseasesHealth Care SurveysConventional PCICardiologyFemaleStentsFranceCardiology and Cardiovascular MedicinebusinessElectrocardiographyTIMICatheterization and Cardiovascular Interventions
researchProduct

Mortality after cardioverter-defibrillator replacement: Results of the DECODE survival score index

2020

Background Device replacement is the ideal time to reassess health care goals regarding continuing implantable cardioverter-defibrillator (ICD) therapy. Only few data are available on the decision making at this time. Objectives The goals of this study were to identify factors associated with poor prognosis at the time of ICD replacement and to develop a prognostic index able to stratify those patients at risk of dying early. Methods DEtect long-term COmplications after implantable cardioverter-DEfibrillator replacement (DECODE) was a prospective, single-arm, multicenter cohort study aimed at estimating long-term complications in a large population of patients who underwent ICD/cardiac resy…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentPopulationReplacementCardiac resynchronization therapy030204 cardiovascular system & hematologyPrognostic indexImplantable cardioverter-defibrillatorNOElectrocardiography03 medical and health sciences0302 clinical medicineInterquartile rangePhysiology (medical)Internal medicinemedicineHumansProspective Studies030212 general & internal medicineeducationShared decision makingAgedOutcomeAged 80 and overHeart Failureeducation.field_of_studyIschemic cardiomyopathybusiness.industryProportional hazards modelMiddle AgedImplantable cardioverter-defibrillatorDefibrillators ImplantableSurvival RateDeath Sudden CardiacItalyFemaleCardiology and Cardiovascular MedicinebusinessDecision Making SharedBody mass indexFollow-Up StudiesCohort study
researchProduct

Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently…

2008

Studies have shown that patients with compensated heart failure (HF) receiving high diuretic doses associated with normal sodium diet and fluid intake restrictions demonstrated significant reductions in readmissions and mortality compared with those who received low-sodium diets, and over a 6-month observation period, a reduction in neurohormonal activation was also observed. The aim of this study was to evaluate the effects of different sodium diets associated with different diuretic doses and different levels of fluid intake on hospital readmissions and neurohormonal changes after 6-month follow-up in patients with compensated HF. Four hundred ten consecutive patients with compensated HF …

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentchemistry.chemical_compoundElectrocardiographyInternal medicineHeart rateNatriuretic Peptide BrainReninmedicineHumansDiureticsAldosteroneAgedRetrospective StudiesHeart FailureAldosteroneEjection fractionmedicine.diagnostic_testDose-Response Relationship Drugbusiness.industryFurosemideSodium DietaryStroke VolumeDiet Sodium-Restrictedmedicine.diseaseBlood pressureTreatment OutcomechemistryEchocardiographyHeart failureCardiologyFemaleDiureticCardiology and Cardiovascular MedicinebusinessElectrocardiographymedicine.drugFollow-Up StudiesThe American journal of cardiology
researchProduct